Q1 Earnings Split: Bajaj Finance Hits High, Thermax Slides 16%

Strides Pharma Science posted a 56.7% rise in profit after tax to Rs 165.5 crore, driven by growth in markets outside the U.S. The company's international business, especially in emerging markets, offset a weaker U.S. generics market. The stock rose 3% on the session.

Swiggy shares fell more than 5% after the company reported narrowed losses in its fiscal first quarter. Brokerages were split on the stock's outlook. Some cited improving unit economics, while others pointed to rising competition and slower growth in food delivery. The narrowed loss alone was not enough to shift sentiment.

The National Stock Exchange reported a 7% increase in Q1 profit to Rs 3,120 crore. The exchange also secured in-principle settlement approval from the Securities and Exchange Board of India, moving closer to its long-awaited initial public offering. The proposed IPO, valued at around Rs 30,000 crore, would be one of the largest equity offerings in India this year.

Friday's reporting slate also included Divis Laboratories, Muthoot Finance, APL Apollo Tubes, Gujarat Ambuja Exports, Clean Science & Technology, and roughly two dozen other companies. The next batch of results is due Monday.